C installed a GE HealthCare SIGNA 1.5T magnetic resonance imaging system at its Novena Specialist Center in Singapore as part of an expansion of its personalised and preventive healthcare capabilities.
The MRI platform will support Tucker Medical’s risk-informed approach to assessment and screening, bringing advanced imaging directly into its specialist care model.
Magnetic resonance imaging can provide detailed visualisation of organs, soft tissue and other anatomical structures without the use of ionising radiation, making it relevant across a range of diagnostic and preventive applications.
The deployment reflects growing interest in integrating advanced imaging earlier into personalised health assessment rather than using imaging solely after symptoms emerge.
Alongside the installation, Tucker Medical and GE HealthCare have signed a memorandum of understanding to explore wider collaboration.
The companies intend to examine opportunities spanning clinical education, knowledge exchange, research support and the advancement of imaging practices across Southeast Asia.
The partnership could also provide a platform for sharing clinical experience and imaging expertise with healthcare professionals in the region.
For Tucker Medical, the addition of MRI expands the range of diagnostic information available within its existing preventive healthcare model.
The clinic focuses on personalised health assessments informed by individual risk factors and longitudinal health information.
The collaboration comes as healthcare systems increasingly explore how imaging, diagnostics and other data sources can support earlier identification of disease risk and more personalised intervention.
For GE HealthCare, the partnership extends the use of its imaging technology within Singapore’s private specialist and preventive healthcare sector while creating opportunities for broader regional education and knowledge exchange.
The relationship highlights a wider shift in medical imaging towards closer integration with preventive and precision healthcare pathways, where diagnostic technologies are used not only to confirm disease but also to support earlier risk assessment and clinical decision-making.
